课题基金 / 基金详情

Metabolism of reactive oxygen species after cerebral ischemia -Study using human SOD1-transgenic mouse-

Metabolism of reactive oxygen species after cerebral ischemia -Study using human SOD1-transgenic mouse-
脑缺血后活性氧的代谢-使用人SOD1-转基因小鼠的研究-
批准号:
14571297
负责人:
SUGAWARA Taku
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

SUGAWARA Taku的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent studies have revealed that activation of extracellular signal-regulated kinase (ERK) may contribute to apoptosis, a cell death process involved in oxidative stress. We examined phosphorylation of ERK1/2 and oxidative stress after transient focal cerebral ischemia (FCI) using transgenic (Tg) mice that overexpress copper/zinc superoxide dismutase (SOD1). The mice were subjected to 60min of middle cerebral artery (MCA) occlusion by intraluminal suture blockade followed by 1,4, and 24 hr of reperfusion. Immunohistochemistry and Western blot analysis showed that phospho-ERK1 was markedly increased in the cortex within the MCA territory at 1 hr of reperfusion (p<0.01), followed by a decrease at 24 hr in wild-type mice. Double staining with phospho-ERK1/2 and neuron-specific nuclear protein showed that phospho-ERK1/2 was primarily expressed in neurons. In SOD1 Tg mice, phospho-ERK1/2 was prominently reduced compared with nonischemic controls, shown by immunohistochemistry. Western blot analysis confirmed a significant decrease in phospho-ERK1/2 1 hr after FCI in the ischemic cortex (p<0.005). Apoptotic-related DNA fragmentation was reduced in the ischemic cortex of SOD1 Tg mice compared with wild-type mice using a cell death assay. These results suggest that phosphorylation of ERK1/2 may be involved in apoptosis or cell death after transient FCI and that SOD1 may attenuate apoptotic cell death mediated by the mitogen-activated protein kinase/ERK pathway.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
菅原卓: "カンデサルタンによる全脳虚血後の神経細胞死抑制効果"Therapeutic Research. 24. 1074-1077 (2003)
Takashi Sukawara:“坎地沙坦对全脑缺血后神经元细胞死亡的抑制作用”治疗研究 24. 1074-1077 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugawara T, Kinouchi H, Mizoi K: "Cerebral ischemia and gene-knockout models."Molecular Cerebrovascular Medicine. 2. 99-105 (2003)
Sukawara T、Kinouchi H、Mizoi K:“脑缺血和基因敲除模型。”分子脑血管医学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
菅原卓, 木内博之, 溝井和夫: "脳虚血とノックアウトモデル"分子脳血管病. 2・1. 99-105 (2003)
菅原隆、木内博之、沟井和夫:“脑缺血和基因敲除模型”《分子脑血管疾病》2·1。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
菅原卓: "カンデサルタンによる全脳虚血後の神経細胞死抑制効果"Therapeutic Research. 24・6. 1074-1077 (2003)
菅原隆:“坎地沙坦对全脑缺血后神经元细胞死亡的抑制作用”治疗研究24・6(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    The role of glycine in neuronal injury after spinal cord injury
    • 批准号:
      22591603
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      SUGAWARA Taku
    • 依托单位:
    Study on local factors in Japanese national elections
    • 批准号:
      21730112
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2009
    • 负责人:
      SUGAWARA Taku
    • 依托单位:
    Amelioration of ischemic neuronal by angiotensin receptor control
    • 批准号:
      18591574
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      SUGAWARA Taku
    • 依托单位:
    国内基金
    海外基金
    EGFR/MAPK/ERK信号通路介导肿瘤相关成纤维细胞分泌TNC导致复发/转移头颈部鳞状细胞癌免疫治疗抵抗的机制研究
    • 批准号:
      JCZRLH202600215
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    肠道菌群代谢物5-HTP负调控MAPK/ERK通路改善孤独症样行为的机制研究
    • 批准号:
      JCZRQNB202600954
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于PD-1/PD-L1调控PI3K/AKT与MAPK/ERK通路探讨栀子苷-大黄素配伍改善脓毒症免疫抑制的作用
    • 批准号:
      2026JJ81015
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢伶俐
    • 依托单位:
    基于PTEN/MAPK/ERK轴的暖巢助孕方干预POI线粒体功能障碍研究